Serological Screening of Newborns for -Specific IgA and IgM Antibodies in Peripheral Blood Collected on Filter-Papers

Overview

Journal EJIFCC

Specialty Biochemistry

Date 2018 Apr 3

PMID 29606933

Citations 1

Authors

Malgorzata Paul

Affiliations

Soon will be listed here.

Abstract

Conclusions: (i) The neonatal screening for anti- IgA and/or IgM antibodies is a good sensitivity method for an early postnatal diagnosis of congenital toxoplasmosis in newborns untreated prenatally. (ii) In the absence of obligatory nation-wide screening during pregnancy followed by an early prenatal treatment, this valuable technique may be considered a preventive option in areas of a high annual number of births associated with a high seroprevalence of infection.

Citing Articles

The cost-effectiveness of neonatal versus prenatal screening for congenital toxoplasmosis.

Binquet C, Lejeune C, Seror V, Peyron F, Bertaux A, Scemama O PLoS One. 2019; 14(9):e0221709.

PMID: 31532766 PMC: 6750576. DOI: 10.1371/journal.pone.0221709.

References

Buffolano W, Gilbert R, Holland F, Fratta D, Palumbo F, Ades A . Risk factors for recent toxoplasma infection in pregnant women in Naples. Epidemiol Infect. 1996; 116(3):347-51. PMC: 2271422. DOI: 10.1017/s0950268800052675. View

Lebech M, Andersen O, Christensen N, Hertel J, Nielsen H, Peitersen B . Feasibility of neonatal screening for toxoplasma infection in the absence of prenatal treatment. Danish Congenital Toxoplasmosis Study Group . Lancet. 1999; 353(9167):1834-7. DOI: 10.1016/s0140-6736(98)11281-3. View

Hohlfeld P . -Toxoplasmosis in pregnancy: arguments in favor of systematic screening in Switzerland-. Arch Gynecol Obstet. 1995; 256 Suppl:S165-9. View

Pinon J, Dumon H, Chemla C, Franck J, Petersen E, Lebech M . Strategy for diagnosis of congenital toxoplasmosis: evaluation of methods comparing mothers and newborns and standard methods for postnatal detection of immunoglobulin G, M, and A antibodies. J Clin Microbiol. 2001; 39(6):2267-71. PMC: 88122. DOI: 10.1128/JCM.39.6.2267-2271.2001. View

FORTIER B, Ajana F . [Toxoplasma gondii: 2 cases of recontamination in immune patients]. Presse Med. 1991; 20(41):2109. View

Berger R, Merkel S, Rudin C . [Toxoplasmosis and pregnancy--findings from umbilical cord blood screening in 30,000 newborn infants]. Schweiz Med Wochenschr. 1995; 125(23):1168-73. View

Jenum P, Stray-Pedersen B, Melby K, Kapperud G, Whitelaw A, Eskild A . Incidence of Toxoplasma gondii infection in 35,940 pregnant women in Norway and pregnancy outcome for infected women. J Clin Microbiol. 1998; 36(10):2900-6. PMC: 105085. DOI: 10.1128/JCM.36.10.2900-2906.1998. View

Bessieres M, Roques C, Berrebi A, Barre V, Cazaux M, Seguela J . IgA antibody response during acquired and congenital toxoplasmosis. J Clin Pathol. 1992; 45(7):605-8. PMC: 495188. DOI: 10.1136/jcp.45.7.605. View

Dzbenski T, Reizer A . [Toxoplasmosis in Poland 1986-1989]. Przegl Epidemiol. 1991; 45(1-2):117-20. View

10.

Malm G, Tear Fahnehjelm K, Wiklund S, Engman M, Ivarsson S, Petersson K . Three children with congenital toxoplasmosis: early report from a Swedish prospective screening study. Acta Paediatr. 1999; 88(6):667-70. DOI: 10.1080/08035259950169369. View

11.

Gras L, Wallon M, Pollak A, Cortina-Borja M, Evengard B, Hayde M . Association between prenatal treatment and clinical manifestations of congenital toxoplasmosis in infancy: a cohort study in 13 European centres. Acta Paediatr. 2006; 94(12):1721-31. DOI: 10.1111/j.1651-2227.2005.tb01844.x. View

12.

Duffy K, Wharton P, Johnson J, New L, Holliman R . Assessment of immunoglobulin-M immunosorbent agglutination assay (ISAGA) for detecting toxoplasma specific IgM. J Clin Pathol. 1989; 42(12):1291-5. PMC: 502063. DOI: 10.1136/jcp.42.12.1291. View

13.

Evengard B, Lilja G, Capraru T, Malm G, Kussofsky E, Oman H . A retrospective study of seroconversion against Toxoplasma gondii during 3,000 pregnancies in Stockholm. Scand J Infect Dis. 1999; 31(2):127-9. DOI: 10.1080/003655499750006146. View

14.

Gavinet M, Robert F, Firtion G, Delouvrier E, Hennequin C, Maurin J . Congenital toxoplasmosis due to maternal reinfection during pregnancy. J Clin Microbiol. 1997; 35(5):1276-7. PMC: 232747. DOI: 10.1128/jcm.35.5.1276-1277.1997. View

15.

Paul M, Petersen E, Pawlowski Z, Szczapa J . Neonatal screening for congenital toxoplasmosis in the Poznań region of Poland by analysis of Toxoplasma gondii-specific IgM antibodies eluted from filter paper blood spots. Pediatr Infect Dis J. 2000; 19(1):30-6. DOI: 10.1097/00006454-200001000-00007. View

16.

Decoster A, DArcy F, Caron A, Vinatier D, Houze de lAulnoit D, Vittu G . Anti-P30 IgA antibodies as prenatal markers of congenital toxoplasma infection. Clin Exp Immunol. 1992; 87(2):310-5. PMC: 1554256. DOI: 10.1111/j.1365-2249.1992.tb02993.x. View

17.

DESMONTS G, Couvreur J, Thulliez P . [Congenital toxoplasmosis. 5 cases of mother-to-child transmission of pre-pregnancy infection]. Presse Med. 1990; 19(31):1445-9. View

18.

Foulon W, Villena I, Stray-Pedersen B, Decoster A, Lappalainen M, Pinon J . Treatment of toxoplasmosis during pregnancy: a multicenter study of impact on fetal transmission and children's sequelae at age 1 year. Am J Obstet Gynecol. 1999; 180(2 Pt 1):410-5. DOI: 10.1016/s0002-9378(99)70224-3. View

19.

Dzbenski T, Kopaczowa G . [Epidemiology and prevention of toxoplasmosis]. Przegl Epidemiol. 1984; 38(2):235-41. View

20.

Aspock H, Pollak A . Prevention of prenatal toxoplasmosis by serological screening of pregnant women in Austria. Scand J Infect Dis Suppl. 1992; 84:32-7. View